GET THE APP

Pharmacoproteomics Journals | Open Access Journals
Molecular Biology: Open Access

Molecular Biology: Open Access

ISSN: 2168-9547

Open Access

Pharmacoproteomics Journals

Pharmacoproteomics is the utilization of proteomic advancements in sedate disclosure and improvement. Alongside pharmacogenomics and pharmacogenetics, pharmacoproteomics will assume a significant job in the improvement of customized medications in a few different ways. Proteomic advances are adding to atomic diagnostics, which is the premise of customized medication. Pharmacoproteomics is an increasingly utilitarian portrayal of patient-to-persistent variety than that given by genotyping. The proteomics-based portrayal of multifactorial ailments may assist with coordinating a specific objective based treatment to a specific marker in a subgroup of patients. Individualized treatment might be founded on differential protein articulation instead of a hereditary polymorphism. At long last, proteomic advancements would empower the revelation and improvement of medications appropriate for customized treatment. Protein chips will be utilized progressively in clinical diagnostics in the following 5 years, especially in the purpose of of-care diagnostics. This will encourage the act of customized medication in the facility before this current decade's over.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Genetics & Molecular Biology

Google Scholar citation report
Citations: 607

Molecular Biology: Open Access received 607 citations as per Google Scholar report

Molecular Biology: Open Access peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward